16-1218399-G-A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2

The NM_021098.3(CACNA1H):​c.5635G>A​(p.Glu1879Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000212 in 1,558,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

4
13
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 6.31

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.78
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5650G>A p.Glu1884Lys missense_variant Exon 32 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5653G>A p.Glu1885Lys missense_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5617G>A p.Glu1873Lys missense_variant Exon 32 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5650G>A p.Glu1884Lys missense_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5596G>A p.Glu1866Lys missense_variant Exon 33 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5617G>A p.Glu1873Lys missense_variant Exon 32 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5578G>A p.Glu1860Lys missense_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5617G>A p.Glu1873Lys missense_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5635G>A p.Glu1879Lys missense_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5635G>A non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1587G>A non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*716G>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3486G>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5079G>A non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*609G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*494G>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1247G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*302G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*302G>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5617G>A non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5635G>A non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5635G>A non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*751G>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1587G>A 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*716G>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3486G>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5079G>A 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*609G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*494G>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1247G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*302G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*302G>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*751G>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152224
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000481
AC:
8
AN:
166398
AF XY:
0.0000566
show subpopulations
Gnomad AFR exome
AF:
0.000230
Gnomad AMR exome
AF:
0.0000789
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000295
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000185
AC:
26
AN:
1405678
Hom.:
0
Cov.:
33
AF XY:
0.0000274
AC XY:
19
AN XY:
694012
show subpopulations
African (AFR)
AF:
0.0000627
AC:
2
AN:
31880
American (AMR)
AF:
0.0000549
AC:
2
AN:
36414
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25292
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36180
South Asian (SAS)
AF:
0.0000880
AC:
7
AN:
79574
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
0.0000120
AC:
13
AN:
1083770
Other (OTH)
AF:
0.0000342
AC:
2
AN:
58456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000459
AC:
7
AN:
152342
Hom.:
0
Cov.:
34
AF XY:
0.0000537
AC XY:
4
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41582
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000340
ESP6500AA
AF:
0.000238
AC:
1
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.0000355
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Mar 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1879 of the CACNA1H protein (p.Glu1879Lys). This variant is present in population databases (rs377103385, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 529614). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1H protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Uncertain
0.025
T
BayesDel_noAF
Uncertain
0.090
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.55
D;.;.;.
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.93
D;D;D;.
M_CAP
Pathogenic
0.63
D
MetaRNN
Pathogenic
0.78
D;D;D;D
MetaSVM
Pathogenic
0.99
D
MutationAssessor
Uncertain
2.8
M;.;.;.
PhyloP100
6.3
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-3.7
D;.;D;D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.015
D;.;D;D
Sift4G
Uncertain
0.025
D;.;D;D
Polyphen
0.46
P;.;D;D
Vest4
0.64
MVP
0.91
ClinPred
0.84
D
GERP RS
4.1
Varity_R
0.52
gMVP
0.72
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377103385; hg19: chr16-1268399; API